跳至主要内容
临床试验/NCT06807333
NCT06807333尚未招募不适用

Transforming Diabetes Care: Pharmacist-Led Education and Its Impact on Patient Knowledge, Self-Management, and Health Outcomes

Shifa International Hospital1 个研究点 分布在 1 个国家目标入组 385 人开始时间: 2025年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
385
试验地点
1
主要终点
Diabetes Knowledge Score(DKQ-24)

研究概览

简要总结

This interventional study is to evaluate the impact of pharmacist-led education on diabetic patients' knowledge, self-management, and overall health outcomes. Participants in this study will attend pharmacist-led educational sessions designed to improve their understanding of diabetes and self-care practices. Researchers will assess changes in patients' knowledge, self-management behaviors, and clinical health markers before and after the intervention. The study will compare pre- and post-intervention results to determine the effectiveness of pharmacist-led education in transforming diabetes care.

详细描述

The purpose of this study is to investigate whether pharmacist-led education can enhance the knowledge, self-management behaviors, and health outcomes of diabetic patients. Effective diabetes management requires a comprehensive understanding of the disease, adherence to lifestyle modifications, and consistent monitoring of health indicators. Poor knowledge and suboptimal self-care can lead to inadequate glycemic control, complications, and reduced quality of life. This study will evaluate the impact of pharmacist-led educational interventions on patients' motivation, diabetes-related knowledge, and self-care behaviors, as well as their effects on clinical outcomes, including improved HbA1c levels, reduced hypo- and hyperglycemic episodes, and enhanced patient satisfaction. By addressing these critical aspects, the study aims to highlight the transformative role of pharmacist-led education in advancing diabetes care and fostering sustainable, patient-centered healthcare practices.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

盲法说明

Participants will be entertained as part of their regular appointment for prescription filling without any information of which group they are assigned in.

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •We will include all confirmed diabetic patients who visit the SIH endocrinology OPD Clinic during the study duration.
  • •Both male and female patients visiting the Endocrinology Unit of the hospital will be eligible.
  • •Patients with HbA1c levels greater than 8% will be included.
  • •Both follow-up and newly diagnosed patients will be considered.
  • •Patients who sign the informed consent form will be enrolled in the study.

排除标准

  • •We will exclude patients with gestational diabetes mellitus (GDM).
  • •Patients with central obesity will not be included in the study.
  • •Type 1 diabetes mellitus (DM) patients under the age of 20 will be excluded.
  • •Patients with inadequate medical history will be excluded from participation.
  • •Patients with HbA1c levels less than 8% will not be included.
  • •Patients who do not provide informed consent or express a lack of interest in the study will be excluded.

研究组 & 干预措施

Interventional Group

Experimental

Lifestyle Modifications: Education on healthy meal choices and physical activity to support diabetes management. Disease Education: In-depth information on diabetes, blood sugar control, and the prevention of complications. Self-Management Tools: Provision of blood glucose monitoring charts and practical strategies for daily diabetes care. Counseling: Personalized counseling to address emotional aspects, stress management, and confidence in managing diabetes.

干预措施: Pharmacist led Education (Behavioral)

结局指标

主要结局

Diabetes Knowledge Score(DKQ-24)

时间窗: 3 months

Patient's diabetes knowledge will be assessed using the Diabetes Knowledge Questionnaire (DKQ). The DKQ is a tool used to evaluate a patient's understanding of diabetes, including aspects such as blood sugar control, diet, exercise, and medication management. It consists of close-ended questions, with scores ranging from 0 to 100, where a higher score indicates a better level of knowledge regarding diabetes management.

Diabetes Management Self-Efficacy Score (DMSQ-16)

时间窗: 3 months

Patient's diabetes self-management will be assessed using the Diabetes Self-Management Questionnaire (DMSQ). The DMSQ is a tool used to evaluate a patient's ability to manage their diabetes through self-care practices, including diet, physical activity, blood sugar monitoring, and medication adherence. It consists of close-ended questions, with scores ranging from 0 to 100, where a higher score reflects better self-management behaviors in managing diabetes.

HbA1C Levels (%)

时间窗: 3 months

Patient's health outcomes will be assessed using HbA1c levels. HbA1c (glycated hemoglobin) is a blood test used to measure a patient's average blood sugar level over the past 3 months. It is a key indicator of diabetes management and glycemic control. The HbA1c level is reported as a percentage, with lower percentages indicating better control of blood sugar. A target HbA1c level of less than 7% is typically recommended for most diabetic patients. The score can range from high percentages (indicating poor control) to lower percentages (indicating better glycemic control).

次要结局

未报告次要终点

研究者

发起方
Shifa International Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

SARA YAHYA

Principal Pharmacist

Shifa International Hospital

研究点 (1)

Loading locations...

相似试验